Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Johnson & Johnson, Memphasys, Procter & Gamble - for a better life

Good health is a valuable possession. Small and large companies around the globe are engaged in research and development to make people's lives easier or better through modern and innovative products and solutions. The consumer goods and pharmaceutical sectors often offer attr...
Mario Hose | April 16, 2020 |

Ellomay Capital Shares Get a Spark from 265 MW Italian Photovoltaic Development Projects

Shares of Israel-based renewable energy firm Ellomay Capital got a jolt today after the firm released details of the development plans for photovoltaic projects in Italy with aggregate capacity of 265 megawatts. Renewable energy and power generator and developer of re...
Streetwise Reports | December 31, 2019 |

Moderna Shares Climb on Development of mRNA Vaccine for Phase 1 Coronavirus Study

Shares of Moderna traded 23% higher after the company reported that it has developed and shipped a mRNA vaccine against novel coronavirus for use in a Phase 1 testing study in the U.S. Yesterday evening, clinical stage biotechnology company Moderna Inc. (MR...
Streetwise Reports | February 26, 2020 |

iBio Shares Trade Up 40% After Announcing Development of Proprietary COVID-19 Vaccine Candidates

iBio Inc. shares traded higher after the company reported that it has filed several provisional patents for its SARS-CoV-2 Virus-Like Particle platform with the U.S. Patent and Trademark Office. Biologics contract manufacturing firm iBio Inc. (IBIO:NYSE.Ame...
Streetwise Reports | March 19, 2020 |

Inovio Pharma Awarded $9M Development Grant for Coronavirus Vaccine

Inovio Pharmaceuticals' shares rose 30%, setting a new 52-week high price, after the firm reported it received a grant of up to $9 million to develop a vaccine against the coronavirus. Among ongoing worldwide concerns, biotechnology firm Inovio Pharmaceuticals Inc. (IN...
Streetwise Reports | January 28, 2020 |

Cortexyme Secures $125M Private Placement Capital to Advance Clinical Development

Shares of Cortexyme Inc. traded 20% higher after the company reported that it secured an additional $125M in capital from a private placement. The firm intends to use the proceeds to fund current Alzheimer's clinical trials and ongoing operations. Clinical s...
Streetwise Reports | February 7, 2020 |

Paratek Pharma Awarded $285 Million BARDA Contract to Combat Anthrax

Shares of Paratek Pharmaceuticals traded 40% higher today after the firm announced it was awarded a BARDA BioShield program contract valued at up to $285 million for NUZYRA used to treat anthrax. Late yesterday afternoon, biopharmaceutical company Paratek Pharmaceuti...
Streetwise Reports | December 20, 2019 |

NCI Chooses Veterinary Biopharma as Select Manufacturing Contractor

The contract's meaning, terms and benefits and the California firm's near-term catalysts are discussed in an H.C. Wainwright & Co. report. In a Sept. 12 research note, H.C. Wainwright & Co. analyst Swayampakula Ramakanth reported that Kindred Biosciences Inc. (KIN:NA...
Streetwise Reports | September 19, 2019 |

Avid Bioservices' Shares Rise on Q2/20 Earnings and Confirmed Outlook

Shares of Avid Bioservices traded higher today, reaching a new 52-week high, after the firm reported Q2/20 earnings and reaffirmed its revenue guidance for Full-Year 2020. After the U.S. financial markets closed yesterday, biologics contract development and manufactur...
Streetwise Reports | December 11, 2019 |

Kyorin's $175M Partnership Offers Good Life for aTyr Pharma in Japan

aTyr Pharma's shares traded 45% higher today after the firm reported that it had entered into a collaboration agreement with Kyorin Pharmaceutical for development and commercialization of its ATYR1923 drug in Japan. This morning, biotherapeutics company aTyr Pharma I...
Streetwise Reports | January 7, 2020 |
1 2 3 4 5 6 7 8 9 10 ...